CEACAM5 and colorectal cancer: A previous study examined sequential changes in serum carcinoembryonic antigen (CEA) levels in colorectal cancer patients treated with ablation for liver metastasis and showed that serum CEA levels initially increased in 65% of patients (11/17) and then gradually decreased to a nadir after 3 months [21].